16th ESCRH Congress - Free Communication: Patient experiences viewing expulsions during medication abortion in the later first trimester
- May 26th, 2022
Patient experiences viewing expulsions during medication abortion in the later first trimester
09:30am Free Communication. Ilana Dzuba, Senior Director, Gynuity Health Projects (USA).
A secondary analysis of findings from two prospective, open-label mifepristone-misoprostol clinical studies evaluating what medication abortion users with 9- to 11-week pregnancies saw on expulsion, their feelings about what they saw, and the effect of viewing pregnancy tissue on satisfaction to inform pre-abortion messaging for users.
Gynuity's presentation is part of the Access to Abortion session that begins at 8:30am on Thursday, May 26.
The 16th Congress of the European Society of Contraception and Reproductive Health will be a hybrid event comprising both an in-person conference and sessions in live streaming. It takes place on May 25-28, 2022 in Ghent, Belgium.